Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-05 12:45:56 ET
Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call March 5, 2026 8:00 AM EST
Company Participants
Greg Mann - Senior Vice President of Investor Relations & Corporate Affairs
Troy Wilson - Chairman, CEO & President
Brian Powl - Chief Commercial Officer
Mollie Leoni - Chief Medical Officer
Thomas Doyle - Senior Vice President of Finance & Accounting
...
Read the full article on Seeking Alpha
For further details see:
Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call Transcript
Kura Oncology Inc.
NASDAQ: KURA
KURA Trading
0.27% G/L:
$9.405 Last:
510,995 Volume:
$9.48 Open:
KURA Latest News
March 06, 2026 07:30:00 am
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2026 06:31:00 am
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026 07:30:00 am
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results
KURA Stock Data
$684,827,867
74,138,925
1.16%
63
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
